| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 07.04. | Update on Internal Matters at AnalytixInsight | 45 | Business Wire | TORONTO--(BUSINESS WIRE)--Certain Directors and Officers of AnalytixInsight Inc. ("AnalytixInsight", or the "Company") (TSX-V: ALY) today provide an update on recent internal matters respecting... ► Artikel lesen | |
| 07.04. | BRISCOE GROUP AUSTRALASIA LIMITED: Annual Report to shareholders | - | ASX | ||
| 07.04. | BRISCOE GROUP AUSTRALASIA LIMITED: Notice of General Meeting/Proxy Form | - | ASX | ||
| 07.04. | How to secure AI system development | - | VentureBeat | ||
| 07.04. | Replimune Group Inc: Interim Results from the ARTACUS Clinical Trial of RP1 Monotherapy in Solid Organ and Hematopoietic Cell Transplant Recipients with Skin Cancers Presented During Oral Presentation at the American Association of Cancer Research (AACR) | 101 | GlobeNewswire (Europe) | SAN DIEGO, April 07, 2024 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of a novel portfolio of oncolytic immunotherapies... ► Artikel lesen | |
| 07.04. | Regeneron Pharmaceuticals, Inc.: Linvoseltamab Pivotal Data Presented at AACR Reinforce High Response Rate that Deepens Over Time in Patients with Heavily Pre-Treated Multiple Myeloma | 118 | GlobeNewswire (Europe) | TARRYTOWN, N.Y., April 07, 2024 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced the oral plenary session presentation of positive pivotal data from the Phase 1/2... ► Artikel lesen | |
| 07.04. | Esperion Therapeutics, Inc.: Esperion Presents Important New Data from CLEAR Outcomes at ACC.24 Highlighting Value of NEXLETOL (bempedoic acid) Tablets in Diverse Populations Including Women, Hispanics/Latinx and Patients with Obesity | 145 | GlobeNewswire (Europe) | - Patients With Obesity Who Took NEXLETOL Were 23% Less Likely to Experience a Major Adverse Cardiovascular Event (MACE-4) Compared to Placebo - - NEXLETOL Demonstrated Clinical Benefit in Historically... ► Artikel lesen | |
| 07.04. | BridgeBio Pharma, Inc.: BridgeBio Pharma Presents Cardiac Magnetic Resonance (CMR) Imaging Evidence Consistent with Clinical Improvement Observed in the ATTRibute-CM Phase 3 Study in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) | 106 | GlobeNewswire (Europe) | - In this exploratory substudy, treatment with acoramidis was associated with possible cardiac structural and functional improvement compared with placebo, with potential cardiac amyloid regression... ► Artikel lesen | |
| 07.04. | Medtronic plc: SMART trial one-year data demonstrates Medtronic Evolut TAVR platform as optimal treatment for severe aortic stenosis in patients with small annulus, which is primarily women | 112 | PR Newswire | New data from largest head-to-head randomized control TAVR trial demonstrates non-inferior clinical outcomes and superior valve performance for Evolut TAVR compared to Sapien at one year
DUBLIN and... ► Artikel lesen | |
| 07.04. | Ionis Pharmaceuticals, Inc.: Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome | 213 | PR Newswire | - Olezarsen met the primary endpoint with statistically significant reduction of fasting triglycerides and showed substantial, clinically meaningful reduction in acute pancreatitis events -
-... ► Artikel lesen | |
| 07.04. | Medtronic plc: New survey uncovers lack of awareness around heart valve disease and risk factors among women | 380 | PR Newswire | Despite prevalence of chronic conditions associated with aortic stenosis in women over 65, the majority have never been referred to a cardiologist; Racial disparities may present further opportunities... ► Artikel lesen | |
| 07.04. | Dizal Pharmaceutical: FDA Grants Breakthrough Therapy Designation to Sunvozertinib for the First-Line Treatment of Patients with advanced Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations | 43 | PR Newswire | SHANGHAI, April 7, 2024 /PRNewswire/ -- Dizal (688192.SH) today announced that the U.S. Food and Drug Administration ("FDA") has granted Breakthrough Therapy Designation (BTD) to its sunvozertinib... ► Artikel lesen | |
| 07.04. | UNITED OVERSEAS BANK LIMITED: REPL::ANNUAL GENERAL MEETING::VOLUNTARY | - | SGX Company Announcements | ||
| 07.04. | YAMADA GREEN RESOURCES LIMITED: GENERAL ANNOUNCEMENT::CAPITAL REDUCTION OF SUBSIDIARY | - | SGX Company Announcements | ||
| 07.04. | PROSPER CAP CORPORATION LIMITED: EXTRAORDINARY/ SPECIAL GENERAL MEETING::VOLUNTARY | - | SGX Company Announcements | ||
| 07.04. | OCEAN SKY INTERNATIONAL LIMITED: ANNUAL GENERAL MEETING::VOLUNTARY | 3 | SGX Company Announcements | ||
| 07.04. | OCEAN SKY INTERNATIONAL LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::RETIREMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR | 2 | SGX Company Announcements | ||
| 07.04. | OCEAN SKY INTERNATIONAL LIMITED: GENERAL ANNOUNCEMENT::CHANGES TO COMPOSITION OF BOARD AND BOARD COMMITTEES | 2 | SGX Company Announcements | ||
| 07.04. | OCEAN SKY INTERNATIONAL LIMITED: ANNUAL REPORTS AND RELATED DOCUMENTS | 2 | SGX Company Announcements | ||
| 07.04. | BAKER TECHNOLOGY LIMITED: ANNUAL GENERAL MEETING::VOLUNTARY | - | SGX Company Announcements |
Seite:
1 2 3 4 5 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| NVIDIA | 3.974 |
| EVOTEC | 3.346 |
| TUI | 2.192 |
| GAMESTOP | 2.060 |
| NEL | 1.955 |
| BAYER | 1.641 |
| BYD | 1.521 |
| RHEINMETALL | 1.346 |
| SMA SOLAR | 1.309 |
| CAVENDISH HYDROGEN | 1.177 |
| DEUTSCHE LUFTHANSA | 1.166 |
| AIXTRON SE | 989 |
| TESLA | 975 |
| SUPER MICRO COMPUTER | 898 |
| VOLKSWAGEN | 797 |
| THYSSENKRUPP | 721 |
| PALANTIR TECHNOLOGIES | 696 |
| DEFI TECHNOLOGIES | 686 |
| APPLE | 654 |
| BASF | 647 |
| BIONTECH | 632 |
| CARL ZEISS MEDITEC | 604 |
| HEIDELBERGER DRUCK | 595 |
| RENK GROUP | 591 |
| DEUTSCHE BANK | 589 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
